ADMA Biologics
ADMA
ADMA
160 hedge funds and large institutions have $592M invested in ADMA Biologics in 2022 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 54 increasing their positions, 38 reducing their positions, and 8 closing their positions.
Holders
160
Holders Change
+30
Holders Change %
+23.08%
% of All Funds
2.58%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
41
Increased
54
Reduced
38
Closed
8
Calls
$11.2M
Puts
$1.39M
Net Calls
+$9.77M
Net Calls Change
+$6.91M
Top Buyers
1 |
1
Millennium Management
New York
|
$20.6M |
2 |
CP
2
Caligan Partners
New York
|
$10.4M |
3 |
3
D.E. Shaw & Co
New York
|
$33M |
4 |
![]()
4
Adage Capital Partners
Boston,
Massachusetts
|
$10.1M |
5 |
KCM
5
Kennedy Capital Management
St Louis,
Missouri
|
$8.73M |